Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)Miguel Á. Sanz, John J. Isitt, Louis M. Aledort et al.|Value in Health|2011Cited by 30